Caplight Directory>Companies>Shanghai CirCode Biomed Co. Ltd.-preview>Circodebio


Shanghai CirCode Biomed Co. Ltd.

Shanghai CirCode Biomed Co. Ltd.

Private
ShanghaiN/Ahttps://www.circodebio.com/

Last Round

Series A

Aug 15, 2023

Company Overview

Shanghai CirCode Biomed Co. Ltd. is a biotechnology company that develops circular RNA (circRNA) therapeutics for cardiovascular diseases, autoimmune disorders, and oncology.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai CirCode Biomed Co. Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shanghai CirCode Biomed Co. Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AAug 15, 2023
Pre SeedDec 16, 2021
AngelJun 29, 2021
View all Funding Rounds

Shanghai CirCode Biomed Co. Ltd. Investors

Notable investors and investment history

InvestorRounds
Kaitai CapitalPre Seed, Angel
Kunlun CapitalPre Seed, Angel
险峰K2VCPre Seed
Efung CapitalPre Seed, Angel
Johnson & Johnson Innovation - JJDC, Inc.Series A
Apricot CapitalAngel
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 15, 2023

    Led by Johnson & Johnson Innovation.

  • Dec 16, 2021

    Led by K2VC with participation from Efung Capital, Kaitai Capital, and Kunlun Capital.

View all signals

Shanghai CirCode Biomed Co. Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai CirCode Biomed Co. Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai CirCode Biomed Co. Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range8
Year Founded2021
Last FundingAug 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.